Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Reception and Implementation of the Japanese Grant of over USD 4 million to 14 Governmental Hospitals

 
Caretaker Deputy Prime Minister and Health Minister Ghassan Hasbani met this morning at his office in Bir Hassan with the Japanese Ambassador H.E. Matahiro Yamaguchi to celebrate the completion of the project of USD 4.289.000 Japanese grant aimed at improving 14 government hospitals in Lebanon; in Beirut: Rafic Hariri University Hospital, In Mount-Lebanon: Siblin, Shahar Gharbi, Daher El Bachek and Bouwar, North Lebanon: El Qoubbeh, Halba, and Sir Danniyeh, Beqaa: Zahleh, Baalbeck, Hermel and Rachaya and in South Lebanon: Marjaoun and Hasbaya.

The meeting was followed by a press conference held by Hasbani and the Japanese Ambassador in the presence of directors of the government hospitals that received the Japanese grant.

Arbid

The advisor to the Minister of Public Health Dr. Bahij Arbid noted that the grant aims at “enhancing the quality of services provided in the government hospitals” as he thanked Minister Hasbani who formed a committee for soft loans and grants, the Japanese Embassy and the action team at the Ministry.

Yamaguchi

The Japanese ambassador stated that Lebanon is one of the best countries in the region as to health care services. However, the Lebanese health care sector is trying to cope with the increasing medical needs of the Lebanese citizens and refugees. For this reason, Japan decided to support the Lebanese Ministry of Public Health with an emergency grant amounting to USD 5 million in order to provide 14 government hospitals with Japanese advanced equipment.

Hasbani

Hasbani thanked Japan for “its interest in the Lebanese hospitalization sector”.

"Many more hospitals benefit and will benefit from other grants provided by the Kuwaiti fund for example, which will focus on improving and equipping the emergency departments, in addition to a part of the world bank grant that will be allocated to the government hospitals as part of the financial project we secured this year,” Hasbani noted.
    1
    ...
ATC Name B/G Ingredients Dosage Form Price ↓
L04AB02 INFLIXIREL BioTech Infliximab - 100mg 100mg Injectable concentrate for solution L.L
V03AC03 DEFERASIROX ARROW G Deferasirox - 360mg 360mg Tablet, coated L.L
B02BD02 BERIATE BioHuman Coagulation Factor VIII - 500IU 500IU Injectable lyophilised powder for solution+diluent L.L
J05AF10 HEPCAVIR 1 G Entecavir monohydrate - 1mg 1mg Tablet, film coated L.L
J05AF10 HEPCAVIR 0.5 G Entecavir monohydrate - 0.5mg 0.5mg Tablet, film coated L.L
B06AC05 TAKHZYRO BioTech Lanadelumab - 300mg/2ml 300mg Injectable solution L.L
N05AX13 TREVICTA B Paliperidone - 525mg 525mg Injectable suspension, prolonged release L.L
N05AX13 TREVICTA B Paliperidone - 350mg 350mg Injectable suspension, prolonged release L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 150mg 150mg Injectable suspension, prolonged release L.L
N05AX13 INVEGA SUSTENNA B Paliperidone palmitate - 100mg 100mg Injectable suspension, prolonged release L.L
L01XX52 VENCLEXTA B Venetoclax - 10mg week 1, Venetoclax - 50mg week 2, Venetoclax - 100mg week 3&4 Tablet L.L
L04AC05 USTEKIREL BioTech Ustekinumab - 90mg 90mg Injectable solution L.L
L04AX04 LENALIDOMIDE NEAPOLIS G Lenalidomide - 15mg 15mg Capsule L.L
L04AX04 LENALIDOMIDE NEAPOLIS G Lenalidomide - 10mg 10mg Capsule L.L
L01CE02 IRINOTECAN GP PHARM G Irinotecan HCl trihydrate - 100mg/5ml 100mg/5ml Injectable concentrated solution L.L
L01XA03 OXALIPLATIN EBEWE G Oxaliplatin - 50mg/10ml 50mg/10ml Injectable concentrated solution L.L
L01CA04 EBERELBIN G Vinorelbine (tartrate) - 50mg/5ml 50mg/5ml Injectable concentrated solution L.L
L01BC01 ALEXAN G Cytarabine - 1,000mg/20ml 1,000mg/20ml Injectable solution L.L
L01CD02 DOCETAXEL EBEWE G Docetaxel - 80mg/8ml 80mg/8ml Injectable solution L.L
L04AA06 MYFORTIC B Mycophenolic acid (sodium) - 360mg 360mg Tablet, gastroresistant L.L
N03AF01 TEGRETOL B Carbamazepine - 2% 2% Suspension L.L
L01DB01 DOXORUBICINE EBEWE G Doxorubicin HCl - 2mg/ml 50mg/25ml Injectable concentrated solution L.L
L01CE02 IRINOTECAN THYMOORGAN G Irinotecan HCl - 40mg/2ml 40mg/2ml Injectable concentrated solution L.L
L01AA06 HOLOXAN B Ifosfamide - 1g 1g Injectable powder for solution L.L
L01AX03 TEGOZOL G Temozolomide - 250mg 250mg Capsule L.L
L01XA03 OXALIPLATINO GP PHARM G Oxaliplatin - 100mg 100mg Injectable lyophilised powder for solution L.L
L04AA44 RINVOQ B Upadacitinib - 15mg 15mg Tablet, prolonged release L.L
L01CD02 DOCETAXEL ACCORD G Docetaxel - 20mg/ml 20mg/1ml Injectable concentrate for solution L.L
L01DC01 BLEOCIN B Bleomycin (sulfate) - 15U 15U Injectable lyophilised powder for solution L.L
J05AB14 VALGANCICLOVIR ARROW G Valganciclovir (HCl) - 450mg 450mg Tablet, coated L.L
    1
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026